Kalaris Therapeutics, Inc. (KLRS)
NASDAQ: KLRS · Real-Time Price · USD
5.89
-0.04 (-0.59%)
At close: Dec 5, 2025, 4:00 PM EST
5.77
-0.12 (-1.95%)
After-hours: Dec 5, 2025, 4:10 PM EST
Kalaris Therapeutics Market Cap
Kalaris Therapeutics has a market cap or net worth of $110.06 million as of December 5, 2025.
Market Cap
110.06M
Enterprise Value
34.61M
1-Year Change
n/a
Ranking
Category
Stock Price
$5.89
Market Cap Chart
Since March 19, 2025, Kalaris Therapeutics's market cap has decreased from $214.52M to $110.06M, a decrease of -48.69%. That is a compound annual growth rate of -60.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 110.06M | -48.69% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 904.62B |
| Johnson & Johnson | 486.51B |
| AbbVie | 399.57B |
| UnitedHealth Group | 299.75B |
| AstraZeneca | 280.82B |
| Novartis AG | 255.15B |
| Merck & Co. | 247.51B |
| Abbott Laboratories | 217.50B |